KVP Capital Advisors’s Terns Pharmaceuticals TERN Stock Holding History

KVP Capital Advisors’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-440,000	Closed	-$23.2M	–	38
2026 Q1	$23.2M	Hold	440,000	–	–	17.32%	1
2025 Q4	$17.8M	Buy	+440,000	New	+$10.2M	17.2%	1

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

KVP Capital Advisors's TERN Position: Q2 2026 in Review

KVP Capital Advisors sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 440,000 shares — an estimated $23.2M sold.

KVP Capital Advisors first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $23.2M in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

KVP Capital Advisors reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
KVP Capital Advisors sold 440,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $23.2M.
KVP Capital Advisors first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
KVP Capital Advisors's Terns Pharmaceuticals position peaked at $23.2M in Q1 2026.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on KVP Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.